Exforge and Bleeding into the skin - a phase IV clinical study of FDA data

Summary:

Bleeding into the skin is reported as a side effect among people who take Exforge (amlodipine besylate; valsartan), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Enbrel, and have Pustular psoriasis.

The phase IV clinical study analyzes which people have Bleeding into the skin when taking Exforge. It is created by eHealthMe based on reports of 12,942 people who have side effects when taking Exforge from the FDA, and is updated regularly.

What is Exforge?

Exforge has active ingredients of amlodipine besylate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 13,350 Exforge users. Check the latest studies of Exforge.

What is Bleeding into the skin?

Bleeding into the skin is found to be associated with 937 drugs and 1,911 conditions by eHealthMe. Check the latest studies of Bleeding into the skin.

On Jul, 16, 2026

12,942 people reported to have side effects when taking Exforge.
Among them, 14 people (0.11%) have Bleeding into the skin.

Could Exforge cause Bleeding into the skin?

Among these 14 people:

How long have people been on Exforge when they have Bleeding into the skin? *

What is the gender of people who have Bleeding into the skin when taking Exforge? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Bleeding into the skin when taking Exforge? *

What are other drugs people take besides Exforge? *

What are other side effects people have besides Bleeding into the skin? *

Immunodeficiency Disorders: 3 people, 21.43%
Injection Site Induration: 3 people, 21.43%
Injection Site Reaction: 3 people, 21.43%
Nosebleed (bleeding from nose): 3 people, 21.43%
Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs): 2 people, 14.29%
Haemorrhage (bleeding): 2 people, 14.29%
Itching: 2 people, 14.29%
Nasopharyngitis (inflammation of the nasopharynx): 2 people, 14.29%
Oedema (fluid collection in tissue): 2 people, 14.29%
Bleeding Disorders: 2 people, 14.29%

What are the existing conditions these people have? *

Pustular Psoriasis (raised bumps on the skin that are filled with pus): 3 people, 21.43%
Prostate Cancer: 2 people, 14.29%
Polymyalgia Rheumatica (pain in many muscles): 2 people, 14.29%
Osteoporosis (bones weak and more likely to break): 2 people, 14.29%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 14.29%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 14.29%
Seasonal Allergy (allergic condition due to certain season): 1 person, 7.14%
Sapho Syndrome (a disorder involving the skin, bone, and joints): 1 person, 7.14%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 7.14%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Exforge and have Bleeding into the skin?

- Check whether Bleeding into the skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exforge:

Exforge (13,350 reports)

Bleeding into the skin treatments and more:

Bleeding into the skin (15,174 reports)

How severe was Bleeding into the skin and when was it recovered:

Bleeding into the skin in Exforge

Expand to all the drugs that have ingredients of amlodipine besylate; valsartan:

Bleeding into the skin and drugs with ingredients of amlodipine besylate; valsartan (14 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exforge:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding into the skin:

Bleeding into the skin (937 drugs)

Browse all the conditions that are associated with Bleeding into the skin:

Bleeding into the skin (1,911 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; valsartan (the active ingredients of Exforge) and Exforge (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.